Research

Consuming the equivalent of one can of soda per day caused mice predisposed to colon cancer to develop larger tumors, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Pulmonologist Dr. Fernando Martinez hopes that a simple questionnaire can help identify patients with COPD who are undiagnosed—and improve countless lives around the globe.

Biochemist Dr. Lewis Cantley is finding increasing evidence of a strong connection between sugar and cancer.

Despite comprising up to 80 percent of global health faculty members and workers, women hold only a fraction of global health leadership roles.

Most of the reasons why American patients receive care from multiple providers are related to numerous modifiable causes such as patient preferences, physician referrals and health system factors —not medical need—according to a qualitative study by Weill Cornell Medicine researchers.  

The third annual NYC Health Hackathonbrought together nearly 200 students and faculty members from Weill Cornell Medicine, Cornell’s Ithaca campus, and several local and national academic institutions, to develop high-tech healthcare innovations. 

Researchers have long known that dysfunction in the body’s innate immune system breaks the first line of defense against invading pathogens, enabling diseases to flourish unchecked.

Building on Cornell’s decades of fundamental and comparative research in the immunological sciences, Provost Michael Kotlikoff has announced the creation of a new Cornell Center for Immunology.

An investigation by Weill Cornell Medicine scientists has yielded two breakthroughs in the pursuit of combating growing resistance to tuberculosis treatments. 

Treating patients with advanced, metastatic esophageal cancer with an immune-system boosting drug called pembrolizumab, known by its brand name Keytruda, led to regression of tumors in some patients, according to results of a phase 2 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

New studies from Weill Cornell Medicine researchers have revealed the importance of two gene-regulation proteins in the development of common immune cell cancers called lymphomas.

Dr. Lisa Newman and her multidisciplinary research team study why breast cancer outcomes vary by patients’ race and ethnicity.

How a soap opera inspired this leading breast cancer surgeon and researcher.

Researchers at WCM–Qatar hope to help Qatar curb its looming diabetes crisis.

A rapid, non-invasive eye exam that uses innovative imaging technology effectively measures the severity of disease in patients with a rare neurodegenerative disease called Friedrich ataxia, according to a study by Weill Cornell Medicine, Weill Cornell Medicine-Qatar and NewYork-Presbyterian researchers.

Researchers at Weill Cornell Medicine, in collaboration with investigators at Dana-Farber Cancer Institute, have been awarded a three-year, $1 million grant from the U.S. Department of Defense (DoD) for prostate cancer clinical trials.

An innovation in gene-splicing technology lands MD-PhD student Dr. Alex Pérez, PhD ’17, on Forbes’s ‘30 Under 30’ list.

The death rate of children whose mothers have died from breast or cervical cancer may be as high as 30 percent in some developing countries, according to a new paper published Nov. 1 in Cancer by Weill Cornell Medicine and NewYork-Presbyterian researchers. 

Older adults with cancer are nearly 70 percent more likely to suffer a stroke or heart attack in the year prior to their diagnosis compared with peers without a cancer diagnosis in that same time period, according to new research by Weill Cornell Medicine, NewYork-Presbyterian and Memorial Sloan Kettering Cancer Center investigators.

A previously unknown type of T lymphocyte, a class of white blood cell, contributes to the development of an autoimmune disease, called lupus, which causes the immune system to attack healthy tissues and organs and leads to chronic inflammation, according to a study led by Weill Cornell Medicine researchers.